FMT is currently used as a treatment for Clostridium difficile infection. The FDA’s regulatory actions are intended to protect patients from unnecessary risk.
Many have criticized the FDA for enacting strict regulations of a treatment that, as of yet, has shown little negative consequence.
More Articles on Gastroenterology:
3 Benefits of Outsourcing Colonoscopy Prep
UHC Recruits Dr. Adam Hansen, Gastroenterology Specialists
AbbVie, Galapagos Partner to Test Possible Chrohn’s Disease Drug
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
